Results 151 to 160 of about 18,459 (198)
Some of the next articles are maybe not open access.

Biguanides

Nihon rinsho. Japanese journal of clinical medicine, 2007
Caroline Day, Clifford J. Bailey
openaire   +3 more sources

[Biguanide].

Nihon rinsho. Japanese journal of clinical medicine, 2015
Metformin, a biguanide, is considered in EASD and ADA to be a first-line glucose-lowering agent for patients with type 2 diabetes. The effectiveness of metformin as an anti-diabetic drug is explained by its ability to lower blood glucose by decreasing hepatic glucose production, stimulating glucose uptake in the muscle, and increasing fatty acid ...
Akio, Ohta, Yasushi, Tanaka
openaire   +1 more source

[Biguanides].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Tomono, Takahashi, Masato, Odawara
openaire   +3 more sources

Biguanides reassessed

Drug and Therapeutics Bulletin, 1969
The biguanides phenformin (Dibotin - Bayer) and metformin (Glucophage - Rona) have been used in the treatment of diabetes for about 10 years. Continuing experience and many new observations have gradually led to changes in their clinical use.
openaire   +1 more source

Contact allergy to polyhexamethylene biguanide (polyaminopropyl biguanide)

Contact Dermatitis, 2021
Nils Hamnerius   +2 more
exaly  

Biguanide

Acta Crystallographica Section B Structural Crystallography and Crystal Chemistry, 1977
S. R. Ernst, F. W. Cagle
openaire   +1 more source

Guanidines and biguanides

Pharmacology & Therapeutics, 1980
openaire   +2 more sources

CHEMISTRY OF THE BIGUANIDES

Annals of the New York Academy of Sciences, 1968
openaire   +2 more sources

Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics

International Journal of Toxicology, 2020
Ronald A Hill   +2 more
exaly  

Home - About - Disclaimer - Privacy